Boehringer Ingelheim Vetmedica, Inc. introduces a vaccine that steps beyond conventional reproductive protection. Express® FP 5-VL5 currently provides one of the most complete modified-live virus/bacterin vaccine combinations on the market, and now it offers protection against Leptospira hardjo-bovis.
Leptospira hardjo-bovis is associated with early embryonic deaths, poor conception rates, weak calves as well as other reproductive losses in cattle. Express FP 5-VL5 offers five-way viral protection and protection against Lepto hardjo-bovis in just one syringe. Lepto hardjo-bovis (Leptospira borgpetersenii serovar hardjo type hardjo-bovis) is the only hardjo that is isolated in the United States; all cattle herds are at risk for infection from it. In a recent study, challenged heifers vaccinated with Express FP 5-VL5 were 100 percent protected against urinary shedding of Lepto hardjo-bovis, while urine culture tests for all heifers in the control group were positive.1
The Express FP line of vaccines for breeding animals offers producers the original written guarantee that no calf persistently infected with BVD will be born from a properly vaccinated cow. It is reproductive and respiratory protection that producers can count on every time.
Read and follow all product label directions. For more information on Express FP, contact your veterinarian or Boehringer Ingelheim Vetmedica, Inc. representative.
For more information, please visit: www.bi-vetmedica.com.
1Protection for Lepto borgpetersenii serovar hardjo using Express FP. BIVI TB10-138.
Express is a registered trademark of Boehringer Ingelheim Vetmedica, Inc. ©2011 Boehringer Ingelheim Vetmedica, Inc.